Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice
Abstract Purpose: To evaluate the impact of the combination of BRL 37344 and tadalafil (TDF) on the reduction of overactive bladder (OB) symptoms. Methods: Thirty mice were randomized into 5 groups (G) of 6 animals each. L-NAME was used to induce DO. G1: Control; G2: L-NAME; G3: L-NAME + TDF; G4: L-NAME + BRL 37344; G5: L-NAME + TDF + BRL 37344. After 30 days of treatment, the animals were submitted to cystometry to evaluate non-voiding contractions (NVC), threshold pressure (TP), baseline pressure (BP), frequency of micturition (FM) and threshold volume (TV). Differences between the groups were analyzed with ANOVA followed by the Tukey test. Results: NVC increased in G2 (4.33±2.58) in relation to G1 (1.50±0.55). NVC decreased in G3 (2.00±1.10), G4 (1.50±1.52) and G5 (2.00±1.26) compared to G2 (p<0.05). FM decreased in G3 (0.97±0.71), G4 (0.92±0.38) and G5 (1.05±0.44) compared to G2 (p<0.05). However, the combination of TDF and BRL37344 was not more effective at increasing NVC and improving FM than either drug alone. The five groups did not differ significantly with regard to TV. Conclusion: The combination of BRL 37344 and TDF produced no measurable additive effect on reduction of OB symptoms.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
2019
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502019000200204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0102-86502019000200204 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0102-865020190002002042019-06-28Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in miceCarvalho,Marcos Fiuza dePamplona,Thuliermes LopesBarreira,Márcio AlencarFechine,Francisco Vagnaldo JacuruGonzaga-Silva,Lúcio FlávioOliveira,Ricardo Reges Maia de Urinary Bladder, Overactive Nitric Oxide Muscle Relaxation Mice Abstract Purpose: To evaluate the impact of the combination of BRL 37344 and tadalafil (TDF) on the reduction of overactive bladder (OB) symptoms. Methods: Thirty mice were randomized into 5 groups (G) of 6 animals each. L-NAME was used to induce DO. G1: Control; G2: L-NAME; G3: L-NAME + TDF; G4: L-NAME + BRL 37344; G5: L-NAME + TDF + BRL 37344. After 30 days of treatment, the animals were submitted to cystometry to evaluate non-voiding contractions (NVC), threshold pressure (TP), baseline pressure (BP), frequency of micturition (FM) and threshold volume (TV). Differences between the groups were analyzed with ANOVA followed by the Tukey test. Results: NVC increased in G2 (4.33±2.58) in relation to G1 (1.50±0.55). NVC decreased in G3 (2.00±1.10), G4 (1.50±1.52) and G5 (2.00±1.26) compared to G2 (p<0.05). FM decreased in G3 (0.97±0.71), G4 (0.92±0.38) and G5 (1.05±0.44) compared to G2 (p<0.05). However, the combination of TDF and BRL37344 was not more effective at increasing NVC and improving FM than either drug alone. The five groups did not differ significantly with regard to TV. Conclusion: The combination of BRL 37344 and TDF produced no measurable additive effect on reduction of OB symptoms.info:eu-repo/semantics/openAccessSociedade Brasileira para o Desenvolvimento da Pesquisa em CirurgiaActa Cirúrgica Brasileira v.34 n.2 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502019000200204en10.1590/s0102-8650201900205 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Carvalho,Marcos Fiuza de Pamplona,Thuliermes Lopes Barreira,Márcio Alencar Fechine,Francisco Vagnaldo Jacuru Gonzaga-Silva,Lúcio Flávio Oliveira,Ricardo Reges Maia de |
spellingShingle |
Carvalho,Marcos Fiuza de Pamplona,Thuliermes Lopes Barreira,Márcio Alencar Fechine,Francisco Vagnaldo Jacuru Gonzaga-Silva,Lúcio Flávio Oliveira,Ricardo Reges Maia de Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice |
author_facet |
Carvalho,Marcos Fiuza de Pamplona,Thuliermes Lopes Barreira,Márcio Alencar Fechine,Francisco Vagnaldo Jacuru Gonzaga-Silva,Lúcio Flávio Oliveira,Ricardo Reges Maia de |
author_sort |
Carvalho,Marcos Fiuza de |
title |
Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice |
title_short |
Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice |
title_full |
Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice |
title_fullStr |
Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice |
title_full_unstemmed |
Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice |
title_sort |
effect of co-administration of brl-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice |
description |
Abstract Purpose: To evaluate the impact of the combination of BRL 37344 and tadalafil (TDF) on the reduction of overactive bladder (OB) symptoms. Methods: Thirty mice were randomized into 5 groups (G) of 6 animals each. L-NAME was used to induce DO. G1: Control; G2: L-NAME; G3: L-NAME + TDF; G4: L-NAME + BRL 37344; G5: L-NAME + TDF + BRL 37344. After 30 days of treatment, the animals were submitted to cystometry to evaluate non-voiding contractions (NVC), threshold pressure (TP), baseline pressure (BP), frequency of micturition (FM) and threshold volume (TV). Differences between the groups were analyzed with ANOVA followed by the Tukey test. Results: NVC increased in G2 (4.33±2.58) in relation to G1 (1.50±0.55). NVC decreased in G3 (2.00±1.10), G4 (1.50±1.52) and G5 (2.00±1.26) compared to G2 (p<0.05). FM decreased in G3 (0.97±0.71), G4 (0.92±0.38) and G5 (1.05±0.44) compared to G2 (p<0.05). However, the combination of TDF and BRL37344 was not more effective at increasing NVC and improving FM than either drug alone. The five groups did not differ significantly with regard to TV. Conclusion: The combination of BRL 37344 and TDF produced no measurable additive effect on reduction of OB symptoms. |
publisher |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia |
publishDate |
2019 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502019000200204 |
work_keys_str_mv |
AT carvalhomarcosfiuzade effectofcoadministrationofbrl37344andtadalafilonreductionofoveractivebladdersymptomsafterinductionofdetrusoroveractivityinmice AT pamplonathuliermeslopes effectofcoadministrationofbrl37344andtadalafilonreductionofoveractivebladdersymptomsafterinductionofdetrusoroveractivityinmice AT barreiramarcioalencar effectofcoadministrationofbrl37344andtadalafilonreductionofoveractivebladdersymptomsafterinductionofdetrusoroveractivityinmice AT fechinefranciscovagnaldojacuru effectofcoadministrationofbrl37344andtadalafilonreductionofoveractivebladdersymptomsafterinductionofdetrusoroveractivityinmice AT gonzagasilvalucioflavio effectofcoadministrationofbrl37344andtadalafilonreductionofoveractivebladdersymptomsafterinductionofdetrusoroveractivityinmice AT oliveiraricardoregesmaiade effectofcoadministrationofbrl37344andtadalafilonreductionofoveractivebladdersymptomsafterinductionofdetrusoroveractivityinmice |
_version_ |
1756401035038949376 |